These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 2693846

  • 1. Pharmacological basis for use of calcium antagonists in hypertension.
    Scriabine A, Kazda S.
    Magnesium; 1989; 8(5-6):253-65. PubMed ID: 2693846
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological basis for use of calcium channel antagonists in hypertension.
    Scriabine A, Kazda S, Garthoff B, Nickerson PA.
    Angiology; 1988 Jan; 39(1 Pt 2):94-9. PubMed ID: 2449099
    [Abstract] [Full Text] [Related]

  • 3. Microcirculatory actions and uses of naturally-occurring (magnesium) and novel synthetic calcium channel blockers.
    Altura BM, Altura BT.
    Microcirc Endothelium Lymphatics; 1984 Apr; 1(2):185-220. PubMed ID: 6400430
    [Abstract] [Full Text] [Related]

  • 4. Nitrendipine and other calcium entry blockers (calcium antagonists) in hypertension.
    Kazda S, Garthoff B, Knorr A.
    Fed Proc; 1983 Feb; 42(2):196-200. PubMed ID: 6822291
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L, Angelico P, Ibba M, Poggesi E, Taddei C, Leonardi A, Testa R.
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [Abstract] [Full Text] [Related]

  • 6. Some recent pharmacological findings with nitrendipine.
    Scriabine A, Anderson CL, Janis RA, Kojima K, Rasmussen H, Lee S, Michal U.
    J Cardiovasc Pharmacol; 1984 Jan; 6 Suppl 7():S937-43. PubMed ID: 6085381
    [Abstract] [Full Text] [Related]

  • 7. [Are all antihypertensive drugs renoprotective?].
    Wolf S, Risler T.
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [Abstract] [Full Text] [Related]

  • 8. Clinical and pharmacological properties of calcium antagonists in essential hypertension in humans and spontaneously hypertensive rats.
    Aoki K, Kawaguchi Y, Sato K, Kondo S, Yamamoto M.
    J Cardiovasc Pharmacol; 1982 May; 4 Suppl 3():S298-302. PubMed ID: 6184557
    [Abstract] [Full Text] [Related]

  • 9. Place of calcium antagonists in the treatment of hypertension.
    Kiowski W.
    Cor Vasa; 1990 May; 32(2 Suppl 1):2-11. PubMed ID: 2200638
    [Abstract] [Full Text] [Related]

  • 10. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M, Koibuchi Y, Sakai S, Tsujioka K, Fujiwara T, Ozaki T, Maeda K, Motoyama I, Horiai H, Ono T.
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [Abstract] [Full Text] [Related]

  • 11. [Differential therapy with calcium antagonists].
    Scholze JE.
    Herz; 2003 Dec; 28(8):754-63. PubMed ID: 14689111
    [Abstract] [Full Text] [Related]

  • 12. Mode of antihypertensive action of nitrendipine.
    Kazda S, Garthoff B, Luckhaus G.
    J Cardiovasc Pharmacol; 1984 Dec; 6 Suppl 7():S956-62. PubMed ID: 6085384
    [Abstract] [Full Text] [Related]

  • 13. Calcium antagonists. Mechanisms, therapeutic indications and reservations: a review.
    Opie LH.
    Q J Med; 1984 Dec; 53(209):1-16. PubMed ID: 6324268
    [Abstract] [Full Text] [Related]

  • 14. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH, Reams GP.
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [Abstract] [Full Text] [Related]

  • 15. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S, Bakir SE.
    Drugs; 2000 Nov; 59 Spec No 2():25-37. PubMed ID: 11002856
    [Abstract] [Full Text] [Related]

  • 16. Nilvadipine: profile of a new calcium antagonist. An overview.
    Rosenthal J.
    J Cardiovasc Pharmacol; 1994 Nov; 24 Suppl 2():S92-107. PubMed ID: 7898101
    [Abstract] [Full Text] [Related]

  • 17. Calcium antagonists and excitation of the vascular muscle membrane.
    Hermsmeyer K, Kuthe C.
    J Cardiovasc Pharmacol; 1984 Nov; 6 Suppl 7():S933-6. PubMed ID: 6085380
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of action of calcium antagonists in hypertension.
    Kiowski W, Bolli P, Erne P, Hulthén UL, Bühler FR.
    J Cardiovasc Pharmacol; 1987 Nov; 10 Suppl 10():S23-8. PubMed ID: 2455134
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.